Negative regulatory pathways of PD-L1 mediated by other posttranslational modifications
Negative regulatory pathways of PD-L1 mediated by other posttranslational modifications. a MMP-7, MMP-9, and MMP-13 cleave the PD-1 binding domain of PD-L1, inhibiting T-cell apoptosis. b PD-L1 proteins undergo methylation by SET7 and demethylation by LSD2. c UFL1 or UFM1 enhances the UFMylation of PD-L1. d ISG15 associates with glycosylated PD-L1, promoting its ISGylation and accelerating the glycosylation-mediated degradation of PD-L1. e Cullin3 promotes NEDDylation, which contributes to the degradation of the PD-L1 protein. f GSH upregulates SERCA activity, suppressing the NF-κB signaling cascade and consequently the transcription of PD-L1. g CK2 induces phosphorylation of ING4, leading to the activation of ING4 and subsequent inhibition of the proteolytic degradation of PD-L1. The black arrows indicate positive regulation, and the red arrows indicate negative regulation
Publication
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways (2024) Rong Wang, et al. Exp Hematol Oncol. 2024;13(NA). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CK2 | CK2 | famplex_relations | CSNK2A1 | 1457 |
| Homo sapiens | Primates | CK2 | CK2 | famplex_relations | CSNK2A2 | 1459 |
| Homo sapiens | Primates | CK2 | CK2 | famplex_relations | CSNK2B | 1460 |
| Homo sapiens | Primates | APC | APC | ncbigene_symbol | APC | 324 |
| Homo sapiens | Primates | APC | APC | ncbigene_synonym | PROC | 5624 |
| Homo sapiens | Primates | UFL1 | UFL1 | ncbigene_symbol | UFL1 | 23376 |
| Homo sapiens | Primates | UFM1 | UFM1 | ncbigene_symbol | UFM1 | 51569 |
| Homo sapiens | Primates | PD-L1 | PD-L1 | ncbigene_synonym | CD274 | 29126 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | PDCD1 | 5133 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | RPL17 | 6139 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | RPL17-C18orf32 | 100526842 |
| Homo sapiens | Primates | MMP9 | MMP9 | ncbigene_symbol | MMP9 | 4318 |
| Homo sapiens | Primates | MMP13 | MMP13 | ncbigene_symbol | MMP13 | 4322 |
| Homo sapiens | Primates | MMP7 | MMP7 | ncbigene_symbol | MMP7 | 4316 |
| Homo sapiens | Primates | LSD2 | LSD2 | ncbigene_synonym | KDM1B | 221656 |
| Homo sapiens | Primates | ISG15 | ISG15 | ncbigene_symbol | ISG15 | 9636 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A1 | 487 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A2 | 488 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A3 | 489 |
| Homo sapiens | Primates | NF-kB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | ING4 | ING4 | ncbigene_symbol | ING4 | 51147 |
| Homo sapiens | Primates | SETD7 | SETD7 | ncbigene_symbol | SETD7 | 80854 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| glutamine | GLUTAMINE | L-glutamine | chebi:18050 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|